Document
Start a New Search
Buy Complete Document: AbstractAbstract Full Text Full Text
Suit aims to block Genzyme acquisition
Boston Globe - Boston, Mass.
Author: Robert Weisman
Date: Aug 20, 2010
Start Page: B.7
Section: Business
Text Word Count: 258
Abstract (Document Summary)

A shareholder of Genzyme Corp. has lodged a lawsuit seeking to block Genzyme board members and the French drug maker Sanofi-Aventis SA from completing a deal in which Genzyme would be acquired by Sanofi for a reported offering price of $69 a share, a transaction that would be valued at about $18.4 billion.

Buy Complete Document: AbstractAbstract Full Text Full Text

Most Viewed Articles  (Updated Daily)

Log In
ProQuest
Search | Saved Search | Login | Tips | FAQ | Pricing | Account | Help | About | Terms

Globe Subscribers

For free access to the archives, log in here.